« Previous
Next »
Schizophrenia Research
Volume 77, Issue 1
, Pages 107-109
, 1 September 2005
Impact of visits from pharmaceutical company representatives on antipsychotic prescription in primary care
References
- . Variations in prescribing atypical antipsychotic drugs in primary care: cross-sectional study. Pharmacoepidemiol Drug Saf. 2002;11:285–289
- . Atypical antipsychotics and glucose dysregulation: a systematic review. Schizophr. Res. 2004;71:195–212
- . Changes in antipsychotic drug prescribing by general practitioners in the United Kingdom from 1991 to 2000: a population-based observational study. Br. J. Clin. Pharmacol. 2003;56:569–575
- . Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study. BMJ. 2002;325:243–247
- . Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior. Jama. 2001;286:1994–1999
-
.
Stata Statistical Software: Release 7.0.
College Station, TX: STATA Corporation; 2001;
- . Pharmaco-epidemiology: what do (and don't) we know about utilisation and impact of psychotropic medications in real-life conditions?. Br. J. Psychiatry. 2004;185:93–94
- . Physicians and the pharmaceutical industry: is a gift ever just a gift?. Jama. 2000;283:373–380
PII: S0920-9964(05)00066-6
doi: 10.1016/j.schres.2005.02.001
© 2005 Elsevier B.V. All rights reserved.
« Previous
Next »
Schizophrenia Research
Volume 77, Issue 1
, Pages 107-109
, 1 September 2005
